CVAT — Cavitation Technologies Balance Sheet
0.000.00%
- $2.56m
- $2.53m
- $0.43m
Annual balance sheet for Cavitation Technologies, fiscal year end - June 30th, USD millions except per share, conversion factor applied.
2019 June 30th | 2020 June 30th | 2021 June 30th | 2022 June 30th | 2023 June 30th | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Equivalents | |||||
Cash and Short Term Investments | 0.649 | 0.759 | 1.36 | 0.441 | 0.018 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 0.24 | 0.104 | 0.006 | 0.001 | 0 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Current Assets | 0.946 | 0.91 | 1.39 | 0.528 | 0.018 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 0.065 | 0.384 | 0.427 | 0.184 | 0.114 |
Long Term Investments | |||||
Other Long Term Assets | |||||
Total Assets | 1.02 | 1.3 | 1.83 | 1.87 | 0.143 |
Payable / Accrued | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 1.84 | 1.43 | 1.79 | 0.558 | 0.864 |
Long Term Debt | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Total Other Liabilities | |||||
Total Liabilities | 1.84 | 1.79 | 2.24 | 0.835 | 1.06 |
Redeemable Preferred Stock | |||||
Non Redeemable Preferred Stock | |||||
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Total Equity | -0.819 | -0.49 | -0.411 | 1.04 | -0.919 |
Total Liabilities & Shareholders' Equity | 1.02 | 1.3 | 1.83 | 1.87 | 0.143 |
Total Common Shares Outstanding |